The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback